Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Dubsky

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Oncology Reports|May 9, 2009
Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinomaThomas Bachleitner-Hofmann, Josef Friedl, Michaela Hassler, et al.
Breast (Edinburgh, Scotland)|August 5, 2025
Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi studyOrit Kaidar-Person, André Pfob, Vincenzo Valentini, et al.
Breast (Edinburgh, Scotland)|August 20, 2025
Corrigendum to "Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi study" [The Breast, Volume 83 (2025) 104537]Orit Kaidar-Person, André Pfob, Vincenzo Valentini, et al.
Cancer Chemotherapy and Pharmacology|February 8, 2008
Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancerRupert Bartsch, Catharina Wenzel, Simon P Gampenrieder, et al.
Breast Cancer Research and Treatment|December 18, 2007
The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)Susanne Taucher, Guenther G Steger, Raimund Jakesz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2025
Erratum: De Novo Oligometastatic Breast CancerLajos Pusztai, Mariya Rozenblit, Peter Dubsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2023
De Novo Oligometastatic Breast CancerLajos Pusztai, Mariya Rozenblit, Peter Dubsky, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2012
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancerRupert Bartsch, Zsuzsanna Bago-Horvath, Anna Berghoff, et al.
Breast Cancer Research and Treatment|January 2, 2004
Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancerSusanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2014
Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility studyKatja Pinker, Wolfgang Bogner, Pascal Baltzer, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Oncology Reports|May 9, 2009
Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinomaThomas Bachleitner-Hofmann, Josef Friedl, Michaela Hassler, et al.
Breast (Edinburgh, Scotland)|August 5, 2025
Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi studyOrit Kaidar-Person, André Pfob, Vincenzo Valentini, et al.
Breast (Edinburgh, Scotland)|August 20, 2025
Corrigendum to "Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi study" [The Breast, Volume 83 (2025) 104537]Orit Kaidar-Person, André Pfob, Vincenzo Valentini, et al.
Cancer Chemotherapy and Pharmacology|February 8, 2008
Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancerRupert Bartsch, Catharina Wenzel, Simon P Gampenrieder, et al.
Breast Cancer Research and Treatment|December 18, 2007
The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)Susanne Taucher, Guenther G Steger, Raimund Jakesz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2025
Erratum: De Novo Oligometastatic Breast CancerLajos Pusztai, Mariya Rozenblit, Peter Dubsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2023
De Novo Oligometastatic Breast CancerLajos Pusztai, Mariya Rozenblit, Peter Dubsky, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2012
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancerRupert Bartsch, Zsuzsanna Bago-Horvath, Anna Berghoff, et al.
Breast Cancer Research and Treatment|January 2, 2004
Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancerSusanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2014
Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility studyKatja Pinker, Wolfgang Bogner, Pascal Baltzer, et al.
Pageof 10